TY - JOUR
T1 - The 12-Item Hypoglycemia Impact Profile (HIP12)
T2 - psychometric validation of a brief measure of the impact of hypoglycemia on quality of life among adults with type 1 or type 2 diabetes
AU - Broadley, Melanie
AU - Chatwin, Hannah
AU - Søholm, Uffe
AU - Amiel, Stephanie A
AU - Carlton, Jill
AU - De Galan, Bastiaan E
AU - Hendrieckx, Christel
AU - McCrimmon, Rory J
AU - Skovlund, Søren E
AU - Pouwer, Frans
AU - Speight, Jane
AU - Hypo-RESOLVE Consortium
PY - 2022/8/17
Y1 - 2022/8/17
N2 - Introduction The aim of this study was to determine the psychometric properties of the 12-Item Hypoglycemia Impact Profile (HIP12), a brief measure of the impact of hypoglycemia on quality of life (QoL) among adults with type 1 (T1D) or type 2 diabetes (T2D). Research design and methods Adults with T1D (n=1071) or T2D (n=194) participating in the multicountry, online study, â € Your SAY: Hypoglycemia', completed the HIP12. Psychometric analyses were undertaken to determine acceptability, structural validity, internal consistency, convergent/divergent validity, and known-groups validity. Results Most (98%) participants completed all items on the HIP12. The expected one-factor solution was supported for T1D, T2D, native English speaker, and non-native English speaker groups. Internal consistency was high across all groups (ω=0.91-0.93). Convergent and divergent validity were satisfactory. Known-groups validity was demonstrated for both diabetes types, by frequency of severe hypoglycemia (0 vs ≥1 episode in the past 12 months) and self-treated episodes (<2 vs 2-4 vs ≥5 per week). The measure also discriminated by awareness of hypoglycemia in those with T1D. Conclusions The HIP12 is an acceptable, internally consistent, and valid tool for assessing the impact of hypoglycemia on QoL among adults with T1D. The findings in the relatively small sample with T2D are encouraging and warrant replication in a larger sample.
AB - Introduction The aim of this study was to determine the psychometric properties of the 12-Item Hypoglycemia Impact Profile (HIP12), a brief measure of the impact of hypoglycemia on quality of life (QoL) among adults with type 1 (T1D) or type 2 diabetes (T2D). Research design and methods Adults with T1D (n=1071) or T2D (n=194) participating in the multicountry, online study, â € Your SAY: Hypoglycemia', completed the HIP12. Psychometric analyses were undertaken to determine acceptability, structural validity, internal consistency, convergent/divergent validity, and known-groups validity. Results Most (98%) participants completed all items on the HIP12. The expected one-factor solution was supported for T1D, T2D, native English speaker, and non-native English speaker groups. Internal consistency was high across all groups (ω=0.91-0.93). Convergent and divergent validity were satisfactory. Known-groups validity was demonstrated for both diabetes types, by frequency of severe hypoglycemia (0 vs ≥1 episode in the past 12 months) and self-treated episodes (<2 vs 2-4 vs ≥5 per week). The measure also discriminated by awareness of hypoglycemia in those with T1D. Conclusions The HIP12 is an acceptable, internally consistent, and valid tool for assessing the impact of hypoglycemia on QoL among adults with T1D. The findings in the relatively small sample with T2D are encouraging and warrant replication in a larger sample.
KW - Adult
KW - Diabetes Mellitus, Type 1
KW - Diabetes Mellitus, Type 2
KW - Humans
KW - Hypoglycemia
KW - Psychometrics
KW - Quality of Life
KW - hypoglycemia
KW - psychometrics
KW - psychosocial issues
KW - quality of life
KW - Psychosocial issuesc
KW - Quality of life
UR - http://www.scopus.com/inward/record.url?scp=85136059263&partnerID=8YFLogxK
U2 - 10.1136/bmjdrc-2022-002890
DO - 10.1136/bmjdrc-2022-002890
M3 - Journal article
C2 - 35977753
SN - 2052-4897
VL - 10
JO - BMJ open diabetes research & care
JF - BMJ open diabetes research & care
IS - 4
M1 - e002890
ER -